Identification of novel protein biomarkers and targets to overcome parp inhibitor resistance
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2110405
- Recipient
-
Mayo Clinic UEI Y2K4F9RPRRG7
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $954,000
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Rochester, MN 55905, USA
Award details come from USAspending.gov.
About this award
The Mayo Clinic will identify novel protein biomarkers and targets to overcome PARP inhibitor resistance under a $954,000 project grant from the Department of the Army Medical Command. The grant was awarded on June 15, 2021 with a completion date of June 14, 2025 under the Military Medical Research and Development program (CFDA 12.420). This program supports basic, applied, and advanced biomedical research to transform military and public health care through innovative medical solutions for battlefield injuries. Through this funding, Mayo Clinic researchers will investigate protein biomarkers and therapeutic targets to help address resistance to PARP inhibitors, a class of drugs used to treat certain cancers. Insights gained from this work could help overcome treatment limitations and improve health outcomes for service members and civilians.
Quick answers
Who received award W81XWH2110405?
W81XWH2110405 was awarded to Mayo Clinic by Medical Command (Department of the Army) on June 15, 2021.
How much is award W81XWH2110405 worth?
$954,000 has been obligated on W81XWH2110405.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award